2024-511119-11-00CompletedPhase 1
A Study of ZW171 in Participants with Advanced or Metastatic Mesothelin Expressing Cancers
Source: EU CTIS (euclinicaltrials.eu) · Last updated 6 Oct 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 25 (actual)
- First submitted
- 1 Aug 2024
- Start date
- 7 Mar 2025
- Lead sponsor
- Zymeworks Inc.
- Diseases
- Lung cancer, Ovarian cancer, Pancreatic cancer
- EU CT number
- 2024-511119-11-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 25
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (3)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Technische Universitaet Dresden | Dresden | Germany | Completed |
| Goethe University Frankfurt | Frankfurt Am Main | Germany | Completed |
| Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR | Mainz | Germany | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.